Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: wolfdog2 who wrote (690)	5/3/1998 7:39:00 PM
From: yosi s	Respond to of 1491

Please do not go to Lucent the best thing is to compare PARS to BTGC once they were at about 2$ they are in the same boat. Story is out but no one covering. Or look at RPC Roberts Pharmaceutical. they got mentioned and the price went from 13 to 17 with same story price went from 9 to 13.5$ PARS same story price 2 to 2.5 to 1.75 to 3.5 Go figure. Thinly traded stocks please check out short intrest I posted it earlier. up over 300,000 from last month. viwes.com Bio tech is a depressed sector. once revenue stream comes in. it suddenly gets a huge multiple. Well unless BOL can Not sell They will go from zero revenues to making profit market really likes those companies that "suddenly" make profit and PARS with its current product has built in growth rate of 50 to 100%. European release market doubles. LE tobra market up 50% to double.. and look at pipeline.. All are waiting to get Phase 2 study results for HU211. Once out a deal will came fast with great term for PARS.